Cosmetic Surgery. Encounter for cosmetic surgery
Conditions
Interventions
Intervention 1: Intervention group 1: dexmedetomidine (manufactured by Razi Company, 1 mcg/kg per ten minutes along with routine anesthesia and maintenance drugs: 6/. mcg/kg per hour). Intervention 2:
Sponsors
Jahrom University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: Physical status of ASA class I, II Filling out the consent form to participate in the study
Exclusion criteria
Exclusion criteria: Unstable hemodynamics at the moment of entering the operating room (systolic pressure less than 90, diastole less than 60 and heart rate less than 60) Taking drugs affecting hemodynamic status Taking anticoagulants drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemodynamic symptoms. Timepoint: Before induction, after induction, 1 minute after induction, 5 minutes after induction, 30, 60, 90 and 120 minutes during operation, entering recovery and exiting recovery. Method of measurement: Monitoring.;Consent of the surgeon. Timepoint: During operation every 15 minutes after the start of surgery. Method of measurement: Beozaart scale.;Bleeding. Timepoint: During surgery and at the end of the operation. Method of measurement: The amount of blood collected in suction and surgical gases. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNavid Kalani
Jahrom University of Medical Sciences
Outcome results
None listed